Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study.

Cédric O RenaudPanos G ZirosAmandine MathiasCaroline Pot Gerasimos P Sykiotis

Published in: Antioxidants (Basel, Switzerland) (2022)

The very low incidence of functional TD indicates an overall very good thyroid tolerance of DMF, arguing against screening for TD in MS patients considered for or treated with DMF, and supporting the further study of Nrf2 activators for the prevention and treatment of TD.

Keyphrases

multiple sclerosis
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
oxidative stress
mass spectrometry
prognostic factors
risk factors
peritoneal dialysis
white matter
patient reported outcomes